Voting results of Cosmo’s 2025 AGM

· Cosmo Pharmaceuticals NV

Cosmo Pharmaceuticals N.V. (“Cosmo”) announced that its shareholders approved all voting items at today’s Ordinary Annual General Meeting. A total of 9,135,061 ordinary shares of the share capital of Cosmo were represented at this general meeting of shareholders. These shares make up 52.07% of the total outstanding ordinary shares in the share capital of Cosmo as of the record date.

Download press release (PDF)

← All news